10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001628280-21-016083`
Period End Date	20210630
Filing Date	20210806
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	ameh-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 108 Income Statement 76 Cash Flow Statement 126 Stockholders Equity 43

Balance Sheet 108 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$103.19M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$177.29M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$193.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$152.44M	USD	Point-in-time
Investments in marketable securities	`MarketableSecuritiesCurrent`	$67.69M	USD	Point-in-time
Investments in marketable securities	`MarketableSecuritiesCurrent`	$187.21M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$7.06M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$16.54M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$68.77M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$49.26M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$4.30M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$4.56M	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$16.80M	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$12.19M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$470.55M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$338.58M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	42.25M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	44.25M	shares	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	12.32M	shares	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	10.89M	shares	Point-in-time
Land, property, and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$29.89M	USD	Point-in-time
Land, property, and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$40.74M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$80.23M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$86.98M	USD	Point-in-time
Assets	`Assets`	$817.49M	USD	Point-in-time
Assets	`Assets`	$894.43M	USD	Point-in-time
Goodwill	`Goodwill`	$239.05M	USD	Point-in-time
Liabilities	`Liabilities`	$347.99M	USD	Point-in-time
Goodwill	`Goodwill`	$239.05M	USD	Point-in-time
Liabilities	`Liabilities`	$372.34M	USD	Point-in-time
Loans receivables	`NotesAndLoansReceivableNetNoncurrent`	$480.00K	USD	Point-in-time
Loans receivables	`NotesAndLoansReceivableNetNoncurrent`	$594.00K	USD	Point-in-time
Loans receivables related parties	`NotesReceivableRelatedPartiesNoncurrent`	$4.14M	USD	Point-in-time
Loans receivables related parties	`NotesReceivableRelatedPartiesNoncurrent`	-	USD	Point-in-time
Investment in other entities equity method	`EquityMethodInvestments`	$43.29M	USD	Point-in-time
Investment in other entities equity method	`EquityMethodInvestments`	$37.37M	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$896.00K	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$37.08M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$16.93M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$18.57M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$18.91M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$8.07M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$423.88M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$478.91M	USD	Point-in-time
Total assets	`Assets`	$817.49M	USD	Point-in-time
Total assets	`Assets`	$894.43M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$53.79M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$36.14M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$9.64M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$9.09M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$58.73M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$59.31M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$70.27M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$50.33M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$2.21M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$4.22M	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$485.00K	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$536.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$102.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$110.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$3.18M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.83M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$205.00K	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$10.89M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$114.99M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$128.09M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$21.24M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$10.96M	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$311.00K	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$249.00K	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$14.51M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$15.87M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$182.71M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$230.21M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.20M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$257.35M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$219.90M	USD	Point-in-time
Total liabilities	`Liabilities`	$347.99M	USD	Point-in-time
Total liabilities	`Liabilities`	$372.34M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$141.86M	USD	Point-in-time
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$114.24M	USD	Point-in-time
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 44,246,796 and 42,249,137 shares outstanding, excluding 10,885,732 and 12,323,164 treasury shares, as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$42.00K	USD	Point-in-time
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 44,246,796 and 42,249,137 shares outstanding, excluding 10,885,732 and 12,323,164 treasury shares, as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$44.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$261.01M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$305.74M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$95.58M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$69.77M	USD	Point-in-time
Total stockholders' equity, parent	`StockholdersEquity`	$330.82M	USD	Point-in-time
Total stockholders' equity, parent	`StockholdersEquity`	$401.36M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$87.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$3.22M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$404.58M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$207.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$349.69M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$197.96M	USD	Point-in-time
Total liabilities, mezzanine equity, and stockholders equity	`LiabilitiesAndStockholdersEquity`	$817.49M	USD	Point-in-time
Total liabilities, mezzanine equity, and stockholders equity	`LiabilitiesAndStockholdersEquity`	$894.43M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$351.70M	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$165.17M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$175.64M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$330.27M	USD	2 Qtrs
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$276.83M	USD	2 Qtrs
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$280.28M	USD	2 Qtrs
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$136.21M	USD	1 Quarter
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$136.08M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$11.56M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$14.20M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$23.39M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$23.66M	USD	2 Qtrs
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$4.63M	USD	1 Quarter
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$9.33M	USD	2 Qtrs
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$4.24M	USD	1 Quarter
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$8.43M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$308.93M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$154.65M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$152.26M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$313.00M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$20.99M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$42.77M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$12.91M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$17.27M	USD	2 Qtrs
(Loss) income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.89M	USD	2 Qtrs
(Loss) income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$834.00K	USD	1 Quarter
(Loss) income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-3.13M	USD	1 Quarter
(Loss) income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-3.81M	USD	2 Qtrs
Gain on sale of equity method investment	`GainLossOnInvestments`	-	USD	1 Quarter
Gain on sale of equity method investment	`GainLossOnInvestments`	$99.65M	USD	1 Quarter
Gain on sale of equity method investment	`GainLossOnInvestments`	-	USD	2 Qtrs
Gain on sale of equity method investment	`GainLossOnInvestments`	$99.65M	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.85M	USD	1 Quarter
Interest expense	`InterestExpense`	$3.38M	USD	2 Qtrs
Interest expense	`InterestExpense`	$5.54M	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.67M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$863.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.79M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$563.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$912.00K	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$67.89M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$69.19M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$1.38M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$1.28M	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$99.95M	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$63.46M	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$100.17M	USD	2 Qtrs
Total other income, net	`NonoperatingIncomeExpense`	$62.91M	USD	2 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$105.68M	USD	2 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$112.86M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$84.45M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$117.44M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$33.45M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$31.70M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$24.92M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$31.86M	USD	1 Quarter
Net loss	`ProfitLoss`	$81.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$83.99M	USD	2 Qtrs
Net loss	`ProfitLoss`	$73.99M	USD	2 Qtrs
Net loss	`ProfitLoss`	$59.53M	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$73.96M	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$46.87M	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$72.89M	USD	2 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$48.18M	USD	2 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$11.10M	USD	2 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$12.66M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$25.81M	USD	2 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$7.04M	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.20	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.31	USD	2 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.60	USD	2 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.29	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.28	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.58	USD	2 Qtrs
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.19	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.30	USD	2 Qtrs

Cash Flow Statement 126 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$81.00M	USD	1 Quarter
Net income	`ProfitLoss`	$83.99M	USD	2 Qtrs
Net income	`ProfitLoss`	$73.99M	USD	2 Qtrs
Net income	`ProfitLoss`	$59.53M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$9.33M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$8.43M	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$741.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$658.00K	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$2.90M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$1.91M	USD	2 Qtrs
Unrealized (gain) loss from investment in equity securities	`UnrealizedGainLossOnInvestments`	$-25.00K	USD	2 Qtrs
Unrealized (gain) loss from investment in equity securities	`UnrealizedGainLossOnInvestments`	$83.77M	USD	2 Qtrs
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.89M	USD	2 Qtrs
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$834.00K	USD	1 Quarter
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-3.13M	USD	1 Quarter
Loss (income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-3.81M	USD	2 Qtrs
Gain on sale of equity method investments	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$99.65M	USD	2 Qtrs
Gain on sale of equity method investments	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	2 Qtrs
Impairment of beneficial interest	`AssetImpairmentCharges`	$15.72M	USD	2 Qtrs
Impairment of beneficial interest	`AssetImpairmentCharges`	-	USD	2 Qtrs
Loss on interest rate swaps	`DerivativeLossOnDerivative`	$1.20M	USD	2 Qtrs
Loss on interest rate swaps	`DerivativeLossOnDerivative`	-	USD	2 Qtrs
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$10.28M	USD	2 Qtrs
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-4.47M	USD	2 Qtrs
Other	`ProceedsFromOtherOperatingActivities`	$189.00K	USD	2 Qtrs
Other	`ProceedsFromOtherOperatingActivities`	-	USD	2 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$6.28M	USD	2 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$9.97M	USD	2 Qtrs
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$19.51M	USD	2 Qtrs
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$11.19M	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-966.00K	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$266.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$-4.61M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$873.00K	USD	2 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$1.65M	USD	2 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$1.68M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$5.09M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$426.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-3.04M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$16.98M	USD	2 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$-174.00K	USD	2 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$-550.00K	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$8.98M	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$11.25M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-2.01M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$37.68M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.25M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.70M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$31.29M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$12.57M	USD	2 Qtrs
Proceeds from repayment of loans receivable related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$31.00K	USD	2 Qtrs
Proceeds from repayment of loans receivable related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$16.50M	USD	2 Qtrs
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$117.00K	USD	2 Qtrs
Purchases of marketable securities	`PrepaymentForInvestmentPurchase`	-	USD	2 Qtrs
Purchases of marketable securities	`PrepaymentForInvestmentPurchase`	$4.45M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.14M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$670.00K	USD	2 Qtrs
Purchase of investment equity method	`PaymentsToAcquireEquityMethodInvestments`	$1.66M	USD	2 Qtrs
Purchase of investment equity method	`PaymentsToAcquireEquityMethodInvestments`	$500.00K	USD	2 Qtrs
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	$52.74M	USD	2 Qtrs
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$451.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.36M	USD	2 Qtrs
Cash received from consolidation of VIE	`ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity`	$3.32M	USD	2 Qtrs
Cash received from consolidation of VIE	`ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity`	-	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.11M	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$67.15M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.80M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$30.19M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$21.11M	USD	2 Qtrs
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$238.21M	USD	2 Qtrs
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$2.38M	USD	2 Qtrs
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$27.00K	USD	1 Quarter
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$61.00K	USD	2 Qtrs
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$54.00K	USD	2 Qtrs
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$35.00K	USD	1 Quarter
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$4.82M	USD	2 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$2.86M	USD	2 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$788.00K	USD	2 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$2.98M	USD	2 Qtrs
Purchase of noncontrolling interest	`PaymentsToMinorityShareholders`	-	USD	2 Qtrs
Purchase of noncontrolling interest	`PaymentsToMinorityShareholders`	$75.00K	USD	2 Qtrs
Proceeds from sale of noncontrolling interest	`ProceedsFromSaleOfNoncontrollingInterest`	$38.00K	USD	2 Qtrs
Proceeds from sale of noncontrolling interest	`ProceedsFromSaleOfNoncontrollingInterest`	-	USD	2 Qtrs
Borrowings on revolver	`ProceedsFromLinesOfCredit`	$180.00M	USD	2 Qtrs
Borrowings on revolver	`ProceedsFromLinesOfCredit`	-	USD	2 Qtrs
Proceeds from sale of shares	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from sale of shares	`ProceedsFromIssuanceOfCommonStock`	$40.13M	USD	2 Qtrs
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$727.00K	USD	2 Qtrs
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-30.55M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-38.17M	USD	2 Qtrs
Net (decrease) increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$49.18M	USD	2 Qtrs
Net (decrease) increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-16.68M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$177.29M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$153.19M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$177.29M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$153.19M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$23.32M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$2.62M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$2.51M	USD	2 Qtrs
Dividend declared included in dividend payable	`DividendsPayableCurrentAndNoncurrent`	$50.00K	USD	Point-in-time
Dividend declared included in dividend payable	`DividendsPayableCurrentAndNoncurrent`	$160.00K	USD	Point-in-time
Preferred shares received from sale of equity investment	`ConversionOfStockAmountIssued1`	-	USD	2 Qtrs
Preferred shares received from sale of equity investment	`ConversionOfStockAmountIssued1`	$36.18M	USD	2 Qtrs
Cancellation of Restricted Stock Awards	`CancellationOfRestrictedStockAwards`	-	USD	2 Qtrs
Cancellation of Restricted Stock Awards	`CancellationOfRestrictedStockAwards`	$144.00K	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$103.19M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$177.29M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$193.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$152.44M	USD	Point-in-time
Restricted cash - noncurrent	`RestrictedCashEquivalentsNoncurrent`	-	USD	Point-in-time
Restricted cash - noncurrent	`RestrictedCashEquivalentsNoncurrent`	-	USD	Point-in-time
Restricted cash - noncurrent	`RestrictedCashEquivalentsNoncurrent`	$746.00K	USD	Point-in-time
Restricted cash - noncurrent	`RestrictedCashEquivalentsNoncurrent`	$75.00K	USD	Point-in-time
Cash, cash equivalents, restricted cash total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Cash, cash equivalents, restricted cash total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$177.29M	USD	Point-in-time
Cash, cash equivalents, restricted cash total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$153.19M	USD	Point-in-time
Cash, cash equivalents, restricted cash total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time

Stockholders Equity 43 line items

Line Item	Tag	Value	Unit	Period
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$404.58M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$207.85M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$349.69M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$197.96M	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$7.33M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$4.15M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$13.70M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$12.67M	USD	1 Quarter
Purchase of noncontrolling interest	`MinorityInterestDecreaseFromRedemptions`	-	USD	1 Quarter
Purchase of noncontrolling interest	`MinorityInterestDecreaseFromRedemptions`	-	USD	1 Quarter
Purchase of noncontrolling interest	`MinorityInterestDecreaseFromRedemptions`	$75.00K	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$301.00K	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$2.45M	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$342.00K	USD	1 Quarter
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$144.00K	USD	1 Quarter
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$236.00K	USD	1 Quarter
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$189.00K	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Sales of noncontrolling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	-	USD	1 Quarter
Sales of noncontrolling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$37.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$2.28M	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$561.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$722.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$4.26M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$852.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.35M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.56M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.06M	USD	1 Quarter
Sale of shares by noncontrolling interest	`StockIssuedDuringPeriodValueAcquisitions`	$40.13M	USD	1 Quarter
Investment in noncontrolling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$3.77M	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$1.16M	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$347.00K	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$404.58M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$207.85M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$349.69M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$197.96M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.